Z-0883-2022 Class II Ongoing
FDA device recall Z-0883-2022 was initiated by Abbott Molecular, Inc. on March 4, 2022 and is designated Class II. Reason for recall: There is a potential for misquantitation high results of negative samples. The recall status is ongoing.
Recall Details
- Product Type
- Devices
- Report Date
- April 13, 2022
- Initiation Date
- March 4, 2022
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Alinity m HBV Application Specification File (US and CE)
Reason for Recall
There is a potential for misquantitation high results of negative samples.
Distribution Pattern
US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam
Code Information
List Numbers: 1) 08N47-03A (US); Version 1.00 2) 08N47-01B (CE); Version 2.00 3) 08N47-01C (CE); Version 3.00